For consortium members

TRUSTING Newsletter Volume 4

Explore the latest project updates and upcoming events. Explore how the TRUSTING trial is accelerating recruitment across countries.

Automated Speech-Based Modeling of Item-Level Symptom Severity in Schizophrenia

Silvia Ciampelli, Janna N de Boer, Sanne Koops, Evan Troelstra, Almut Jebens, Jan-Bernard C Marsman, Arnout C Smit, Amir Hossein Nikzad, Ryan Partlan, Philipp Homan, Wolfram Hinzen, Sunny X Tang, Iris E C Sommer | Published: 25 June 2026 Importance: Speech carries subtle indicators of current mental state, a phenomenon routinely used in psychiatric assessment. Despite its potential, quantitative speech analysis is not yet integrated into clinical care. Objective: To […]

Using AI to Detect Psychosis Relapse: Scoping Review

Lorenzo Ghelfi, Jack Healy, Francesco Piacenza, Ian French, Nicholas McNamara, Khyber Afridi Rabbi, Benjamin Bond, Emma O’Hora, Darren Roddy, Moyyad Kamali, Sudipto Das, Sandra Anna Just, Enrico Tedeschi, Musarrat Hussain, Karl Øyvind Mikalsen, Stefan Kaiser, Giacomo Cecere, Sanne Koops, Janna de Boer, Elysie Nguyen, Emre Bora, Wolfram Hinzen, Philipp Homan, Iris E Sommer, David Cotter, Mary Cannon, John Paul Lyne | Published: 16 June 2026 Background: Psychotic disorder represents a leading cause of disability worldwide, and relapse in psychosis is common. Artificial intelligence […]

The challenges of implementing hybrid baselines for the interpretation of longitudinal behavioral data from individuals

Sandra Anna Just,  Enrico Tedeschi,  Einar Holsbø,  Karl Øyvind Mikalsen,  Lars Ailo Bongo,  Philipp Homan &  Brita Elvevåg | Published: 22 April 2026 Establishing whether observed behavioral differences reflect meaningful change in an individual necessitates baselines specific to the individual and task. Automated hybrid solutions combine adaptive baselines with fixed thresholds. Applying this approach to behavioral science harbors […]

TRUSTING Project Showcased at International Conferences in March 2026

At the end of March 2026, the TRUSTING project gained strong visibility across two major international conferences, reinforcing its role in advancing innovative and trustworthy approaches in mental health research. From 25–29 March 2026, TRUSTING was represented at the Schizophrenia International Research Society (SIRS) Conference in Florence. The event connected leading experts in psychosis research, […]

The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data

Attila Imre,  Ágota Mészáros,  Bertalan Németh,  Balázs Nagy,  Judit Józwiak-Hagymásy,  Giacomo Cecere,  Philipp Homan,  Iris E. C. Sommer &  Balázs Babarczy Published: 27 March 2026 Background Existing studies on the economic impact of schizophrenia are fragmented and vary in methodology, hindering an ample understanding of the total economic burden. Aims To quantify the global economic burden of schizophrenia […]

TRUSTING Newsletter Volume 3

Explore how TRUSTING’s clinical study is now actively recruiting across Europe, and learn how everyday speech is being used to detect psychosis relapse across five countries and six languages.

Can Speech Alone Reveal Psychosis Symptoms? TRUSTING Study Shows Promising Results

The EU-funded TRUSTING Project has achieved a major research milestone in Work Package 2 (WP2). Showing that speech recordings alone can help predict symptom severity in people living with psychosis, without analysing what is actually being said. Predicting Psychosis Symptoms Using Speech Audio Only In a large international, multi-centre retrospective study covering ten languages. Researchers […]

Inside TRUSTING: New Video Series Shows How AI and Speech Could Transform Psychosis Care

How can everyday speech help predict relapse in psychosis? And how can artificial intelligence support clinicians and patients in identifying early warning signs in a safe and trustworthy way? To answer these questions, the TRUSTING project has released two new videos offering an inside look at the clinical study and the technology behind its speech-based […]